Synapse - Works

Results (115824)

Deep learning algorithm improves identification of men with low-risk prostate cancer using PSMA-targeted (99m)Tc-MIP-1404 SPECT/CT

Meeting Abstract

Meyer, A.; Stambler, N.; Sjöstrand, K.; Richter, J.; Allaf, M.; Rowe, S. P.; Wong, V.; Anand, A.; Gorin, M. A.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Relationship between clinical efficacy and AEs of IMCgp100, a novel bispecific TCR-anti-CD3, in patients with advanced melanoma

Meeting Abstract

Middleton, M. R.; Steven, N. M.; Evans, T. R. J.; Infante, J. R.; Sznol, M.; Hamid, O.; Shoushtari, A. N.; Anthoney, A.; Gupta, A.; Woodcock, V. K.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Biomarker predictors of outcome from a randomized trial of nivolumab +/- stereotactic body radiotherapy (SBRT) in metastatic (M1) head and neck squamous cell carcinoma (HNSCC)

Meeting Abstract

McBride, S. M.; Lee, N. Y.; Pfister, D. G.; Sherman, E. J.; Tsai, C. J.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D. C.; Michel, L. S.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Baseline genomic and circulating tumor cell (CTC) correlative data from very high-risk (VHR), localized, node-negative prostate cancer patients

Meeting Abstract

McBride, S. M.; Zelefsky, M. J.; Spratt, D. E.; Paller, C. J.; Kollmeier, M.; Slovin, S. F.; Aghalar, J.; Hearn, J. W. D.; Den, R. B.; Deville, C.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

CheckMate 214 post-hoc analyses of nivolumab plus ipilimumab or sunitinib in IMDC intermediate/poor-risk patients with previously untreated advanced renal cell carcinoma with sarcomatoid features

Meeting Abstract

McDermott, D. F.; Choueiri, T. K.; Motzer, R. J.; Aren, O. R.; George, S.; Powles, T.; Donskov, F.; Harrison, M. R.; Cid, J. R. R. R.; Ishii, Y.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Tumor mutation burden and depression in lung cancer: Association with inflammation

Meeting Abstract

McFarland, D. C.; Jutagir, D. R.; Rosenfeld, B.; Miller, A. H.; Nelson, C. J.; Breitbart, W.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

A phase Ib dose-escalation and cohort-expansion study of safety and activity of the transforming growth factor (TGF) β receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer

Meeting Abstract

Melisi, D.; Hollebecque, A.; Oh, D. Y.; Calvo, E.; Varghese, A. M.; Borazanci, E. H.; Mercade, T. M.; Simionato, F.; Park, J. O.; Bendell, J. C.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Trends in financial relationships between industry and individual medical oncologists in the United States from 2014 to 2017: A cohort study

Meeting Abstract

Marshall, D. C.; Tarras, E. S.; Rosenzweig, K.; Korenstein, D.; Chimonas, S.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Maintenance olaparib after platinum-based chemotherapy in patients (pts) with newly diagnosed advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): Efficacy by surgical and tumor status in the Phase III SOLO1 trial

Meeting Abstract

Mathews, C. A.; Moore, K. N.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A. S.; Floquet, A.; Leary, A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

A multicenter, randomized phase III study of asciminib (ABL001) versus bosutinib in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) previously treated with ≥2 tyrosine kinase inhibitors (TKIs)

Meeting Abstract

Mauro, M. J.; Hochhaus, A.; Boquimpani, C.; Minami, Y.; Allepuz, A.; Polydoros, F.; Bédoucha, V.; Aimone, P.; Réa, D.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save